NuGen Medical Devices Inc.
NGMD.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.73M | -1.36M | -1.68M | 1.09M | 364.50K |
| Total Depreciation and Amortization | 143.50K | 123.10K | 118.40K | 109.80K | 113.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.93M | 517.10K | 985.20K | -1.65M | -947.00K |
| Change in Net Operating Assets | -48.20K | -50.20K | 65.40K | -123.80K | -1.53M |
| Cash from Operations | -704.50K | -765.40K | -513.20K | -571.00K | -1.99M |
| Capital Expenditure | -124.80K | -54.70K | -38.30K | -- | -7.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00 | -800.00 | -- | -- | -300.00 |
| Cash from Investing | -125.00K | -55.50K | -38.30K | -- | -7.70K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 60.50K | 405.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 42.20K | 289.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -829.60K | -820.90K | -551.40K | -528.90K | -1.71M |